Selected article for: "able state and lung injury"
Author: Rice, Shawn J.; Hyland, Victoria; Behera, Madhusmita; Ramalingam, Suresh S.; Bunn, Paul; Belani, Chandra P.
Title: Guidance on the clinical management of E-cigarette or Vaping Associated Lung Injury (EVALI)?
  • Cord-id: rdg31p17
  • Document date: 2020_8_29
    • ID: rdg31p17
    Snippet: In the summer of 2019 there was a rise in clusters of adolescents and young adults in the United States reporting to emergency departments with acute respiratory distress related to e-cigarette or vaping usage. The number of patients with E-cigarette or Vaping Associated Lung Injury (EVALI) continued to rise through the summer before peaking in September 2019. Through the efforts of state and federal public health agencies, officials were able to define the condition, identify the relationship o
    Document: In the summer of 2019 there was a rise in clusters of adolescents and young adults in the United States reporting to emergency departments with acute respiratory distress related to e-cigarette or vaping usage. The number of patients with E-cigarette or Vaping Associated Lung Injury (EVALI) continued to rise through the summer before peaking in September 2019. Through the efforts of state and federal public health agencies, officials were able to define the condition, identify the relationship of the respiratory injury to tetrahydrocannabinol (THC)-containing products, and stem the rise in new cases. In this report, we present a comprehensive review of the clinical characteristics and features of EVALI patients and present guidelines for patient care and management to inform and navigate clinicians who may encounter these patients in their clinical practice.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute effect: 1
    • absence presence and acute respiratory symptom: 1
    • absence presence and low number: 1, 2, 3
    • absence presence and lung damage: 1, 2
    • absence presence and lung injury: 1, 2, 3, 4
    • absence presence and lung injury response: 1, 2
    • absence presence and lymph node: 1, 2, 3, 4, 5
    • action mechanism and acute effect: 1, 2, 3, 4, 5
    • action mechanism and lung damage: 1, 2, 3, 4, 5, 6
    • action mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • action mechanism and lung injury cause: 1
    • action mechanism and lung injury response: 1, 2
    • action mechanism and lung toxicity: 1, 2
    • action mechanism and lymph node: 1, 2, 3
    • acute effect and lung damage: 1, 2, 3, 4
    • acute effect and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acutely ill and lung damage: 1
    • acutely ill and lung injury: 1
    • adolescent patient and lung injury: 1